Wes Hoffmann's Avatar

Wes Hoffmann

@wesjhoffmann.bsky.social

ID PharmD at Houston Methodist TMC. Interested in AMS and immunocompromised ID. Interests outside of ID include my kiddo, college basketball (Purdue specifically), and nature/animals!

968 Followers  |  548 Following  |  3 Posts  |  Joined: 05.08.2023  |  1.7563

Latest posts by wesjhoffmann.bsky.social on Bluesky


I suppose it’s somewhat dependent. Most of the patients I see with urine source GNR bacteremia are older and frequently have some component of CKD, in which case 1g TID is my go to simply to make it easier for them. If it was a young patient, excellent clearance, would lean toward QID.

30.12.2024 23:58 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Glad my memory was serving me correctly there! I don’t suppose there is a good publication on this that I can have stored away for future?

12.11.2024 20:24 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Midlines were used regularly and preferentially for less than 2 week durations. If I recall correctly though at a prior institution, the vascular access team would avoid with vanc OPAT (even <2 weeks) as they felt the vanc caused more vascular problems in midlines (need to find the data).

12.11.2024 00:50 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

@wesjhoffmann is following 20 prominent accounts